Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

New mRNA cancer vaccine has a key difference from most jabs

The experimental Moderna melanoma vaccine can't prevent melanoma, but it can be used to treat the cancer.

Inverse

‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer

The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumours

The Guardian - UK

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Stock Leaps On Positive Data From Late-Stage RSV Vaccine Trial

"We are committed to developing a portfolio of respiratory mRNA vaccines to target the most significant viruses causing respiratory disease, including COVID-19, influenza, and human metapneumovirus," said CEO Stéphane Bancel.

The Street

Stocks Waver, Retail Sales, United Airlines, Moderna, Albertsons - Five Things To Know

Stock futures waver, bonds rally on Bank of Japan surprise; December retail sales in focus amid gas price retreat; United Airlines shares higher on earnings beat, bullish outlook; Moderna shares leap on positive data from RSV drug trial and Albertsons gets court approval for $4 billion dividend payment.

The Street

Dow Jones Futures Rise On Bank Of Japan Surprise; Tesla, Moderna Lead Early Movers

Futures rose and yields fell as the Bank of Japan stayed dovish. The market rally paused while Tesla stock jumped. United Airlines, Moderna rose overnight. Microsoft job cuts loom.

Investors Business Daily

Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market

Moderna stock surged early Wednesday after the company said its experimental RSV vaccine proved nearly 84% effective.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works

Media outlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.

The Conversation

The US government spent $30bn developing the Covid vaccine. So how can Moderna plan to charge $110 a jab?

Vaccines were built in part on government research and funding, but treatment won’t be free to Americans much longer

The Independent UK

Elon Musk Amplifies Bernie Sanders's Outrage Against Moderna

The pharmaceutical company is mulling a move that has enraged both Musk and one of his ideological opposites.

The Street

Bernie Sanders Begs Moderna Not to Follow in Pfizer's Footsteps

Big pharma has money to make and the covid vaccine is fertile ground for revenue. But at least one U.S. politician is urging caution.

The Street

Bivalent COVID vaccines have now been in use for a few months – here's how they're stacking up against omicron

Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They’re estimated to have saved tens of millions of lives around the globe.

The Conversation

The 'Kraken' COVID variant taking hold in the U.S. Here's how many vaccine shots there are—and what experts recommend to protect yourself

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

Fortune

Vaccines are not making COVID strains like 'Kraken' stronger

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Investors Business Daily

Genetics, Alzheimer's And AI — Why 2023 Could Be The Year For Biotech Stocks

If there's one biotech area to watch in 2023, it's genetic medicine, like CRISPR. But other trends also point to a big year for biotech stocks.

StockNews.com

Investing Champion Leif Soreide Notes Biotech Stocks May Be Countercyclical

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

The National (Scotland)

Tory MP condemns colleague's 'nonsense' claims about Covid vaccines

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Covid could help to cure cancer, new research reveals

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

Tribune News Service

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

WEKU

How a scrappy African startup could forever change the world of vaccines

Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed?

Investors Business Daily

Dow Jones Futures Rise, Tesla Bounces After Leading Growth Sell-Off; 5 Stocks Near Buy Points

Tesla bounced early after leading a growth sell-off with Moderna and Nvidia. Many industrial and energy plays are thriving

StockNews.com

2 Biotech Stock to Buy Over Moderna This December

Biotech giant Moderna (MRNA) missed consensus revenue and EPS estimates in its 2022 third quarter. Moreover, it lost more than 17% in 2022. While analysts are bearish on MRNA’s growth, the industry prospects look bright. Therefore, investors looking to invest in biotech stocks could consider buying Biogen (BIIB) and Jazz…

Investors Business Daily

Stock Market Feels Winter Chill; Disney No Longer Happiest Place On Earth; Musk Monday Madness

Disney weighed on the Dow Jones after Avatar 2 missed box office numbers.

Investors Business Daily

Dow Jones Falls As Stock Market Continues To Drop; Tesla Down After Elon Musk Twitter Poll

The Dow Jones Industrial Average fell Monday after last week's heavy losses. Tesla stock jumped early on Elon Musk's Twitter poll that said he should step down, but quickly reversed lower.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.